Zhang et al. [39] indicated that patients with CC and TT genotypes for ABCG2 rs2231142 and rs1045642 of ABCB1, respectively, had a higher risk of CML development. Here, ABCG2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.